跳至主要内容
临床试验/ACTRN12620000564954
ACTRN12620000564954招募中未知

Evaluation of Outcomes Following Tricuspid Valve Cylinder Reconstruction with CardioCel® in Isolated Severe Tricuspid Regurgitation

The Alfred0 个研究点目标入组 10 人开始时间: 2020年5月14日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 85 Years(—)
性别
All

入选标准

  • Is ambulatory, able and willing to comply with the study protocol and has provided written informed consent
  • Aged 18-85 years, inclusive
  • Symptomatic with TR grade greater than or equal to 3+
  • Preserved right ventricular function
  • In the opinion of the investigator and heart surgery team, the patient is not an appropriate candidate for tricuspid annuloplasty

排除标准

  • In the opinion of the investigator and heart surgery team, the patient is an appropriate candidate for tricuspid annuloplasty
  • Haemodynamic instability (systolic pressure < 90mmHg without after load reduction or cardiogenic shock or the need for inotropic support or intra-aortic balloon pump)
  • Model for End-stage Liver Disease (MELD score) > 15
  • Suspected inability to adhere to adhere to follow-up
  • Patients in whom TTE, TOE, (or MRI) is contraindicated
  • A known need for any other cardiac surgery
  • Inability to give informed consent

研究者

发起方
The Alfred

相似试验